MINERVA CARDIOANGIOLOGICA

Helicobacter pylori and cardiovascular disease: update 2019.

Novel transcatheter therapies for treating tricuspid regurgitation.

Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fraction.

Baseline indicators of coronary artery disease burden in patients with non-ST-segment elevation acute coronary syndrome.

Implications of the new 2017 American College of Cardiology/American Aeart Association Guidelines for Hypertension.

Antihypertensive effect of sacubitril/valsartan: a meta-analysis.

Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study.

Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin.

Degeneration of prosthesis after transcatheter aortic valve implantation.

Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.

A novel approach to quantification of aortic valve calcifications in patients undergoing transcatheter aortic valve implantation.

A simple prognostic index in acute heart failure.

Incidence of infective endocarditis before and after the guideline modification regarding a more restrictive use of prophylactic antibiotics therapy in the USA and Europe.

Effectiveness of the ECG method in the correct positioning of PICC type central venous catheters in patients with atrial fibrillation.

Exercise and atrial fibrillation: how health turns harm, and how to turn it back.

Electrocardiographic conduction and repolarization markers associated with sudden cardiac death: moving along the electrocardiography waveform.

The prognostic value of mean platelet volume to platelet count ratio in older patients with non-ST elevation acute coronary syndrome receiving primary percutaneous coronary intervention: a retrospective study.

Prospective registry on cerebral oximetry-guided transcarotid TAVI in patients with moderate-high risk aortic stenosis.

Could mechanical thrombectomy replace thrombolysis in the treatment of acute and subacute limb ischemia?

Comparative analysis for the implication of serum cardiac troponin measurements by conventional versus high-sensitivity assays in patients with traumatic brain injury.

The association between non-alcoholic fatty liver disease and valvular heart disease.

Long-term rhythm monitoring with an implantable loop recorder in patients after the first clinical atrial fibrillation episode. Towards an individualized management.

Novel ultra-long (48 mm) everolimus-eluting stent for diffusely coronary vessels disease.

Neuroprotective measures throughout the TAVI pathway.

Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide.

Validation of a new score for outcome prediction in patients with heart failure with reduced ejection fraction.

Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®.

Heart rate variability in sick sinus syndrome: does it have a diagnostic role?

Hybrid ablation for atrial fibrillation: the importance of achieving transmurality and lesion validation.

The association of the S447X mutation in LPL with Coronary artery disease: a meta-analysis.

Ablation, rate or rhythm control strategies for patients with atrial fibrillation: how do they affect mid-term clinical outcomes? A retrospective cohort study.

Use of DOACs in real-world challenging settings: a Delphi Consensus from Italian cardiologists.

Effects of dronedarone on all-cause mortality and on cardiovascular events in patients treated for atrial fibrillation: a meta-analysis of RCTs.

NOACs for coronary or peripheral artery disease: a systematic review and meta-analysis of mortality and major bleeding.

New percutaneous interventions in heart failure.

Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®.

Central cardiovascular calcifications: supplementtion with Pycnogenol® and Centellicum®: variations in 12 months.

Everolimus-eluting bioresorbable vascular scaffolds: learning from the past to improve the future.

Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques; 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.

Benefits of pressure-controlled hemostasis for transradial vascular access: a randomized controlled trial.

The role of optimal lesion preparation for de novo coronary vessels, when a stent-less intervention strategy is planned.

Relationships between left ventricular geometry (sphericity index) and remodeling in dilated cardiomyopathy.

Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.

Long term clinical outcomes of direct Absorb bioresorbable vascular scaffold implantation in acute coronary syndrome.

Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.

Cell therapy and left ventricular restoration for ischemic cardiomyopathy: long-term results of a perspective, randomized study.